Evidence-based guidelines for interpreting change scores for the European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire Core 30.

[1]  D. Osoba,et al.  Minimal clinically meaningful differences for the EORTC QLQ-C30 and EORTC QLQ-BN20 scales in brain cancer patients. , 2011, Annals of oncology : official journal of the European Society for Medical Oncology.

[2]  P. Fayers,et al.  Evidence-based guidelines for determination of sample size and interpretation of the European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire Core 30. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[3]  D. Osoba,et al.  Minimal important differences for interpreting health-related quality of life scores from the EORTC QLQ-C30 in lung cancer patients participating in randomized controlled trials , 2011, Supportive Care in Cancer.

[4]  D. Osoba,et al.  Patient Related Outcome Measures Dovepress Meta-analysis Provides Evidence-based Interpretation Guidelines for the Clinical Significance of Mean Differences for the Fact-g, a Cancer-specific Quality of Life Questionnaire , 2022 .

[5]  D. Osoba,et al.  Meta-analysis provides evidence-based effect sizes for a cancer-specific quality-of-life questionnaire, the FACT-G. , 2010, Journal of clinical epidemiology.

[6]  L. Hedges,et al.  The Handbook of Research Synthesis and Meta-Analysis , 2009 .

[7]  Galina Velikova,et al.  Quality, interpretation and presentation of European Organisation for Research and Treatment of Cancer quality of life questionnaire core 30 data in randomised controlled trials. , 2008, European journal of cancer.

[8]  D. Redelmeier,et al.  Interpreting clinically significant changes in patient‐reported outcomes , 2007, Cancer.

[9]  D. Cella,et al.  Meaningful change in cancer-specific quality of life scores: Differences between improvement and worsening , 2002, Quality of Life Research.

[10]  M. King.  The interpretation of scores from the EORTC quality of life questionnaire QLQ-C30 , 1996, Quality of Life Research.

[11]  M. Groenvold,et al.  Quality of life of Danish women: Population-based norms for the EORTC QLQ-C30 , 2004, Quality of Life Research.

[12]  P. Fayers.  Interpreting quality of life data: population-based reference data for the EORTC QLQ-C30. , 2001, European journal of cancer.

[13]  A. Hinz,et al.  Reference data for the quality of life questionnaire EORTC QLQ-C30 in the general German population. , 2001, European journal of cancer.

[14]  Mark W. Lipsey,et al.  Practical Meta-Analysis , 2000 .

[15]  Y. Brandberg,et al.  Health-related Quality of Life Measured by the EORTC QLQ-C30: Reference Values From a Large Sample of the Swedish Population , 2000 .

[16]  P. Fayers,et al.  Health-related quality of life in the general Norwegian population assessed by the European Organization for Research and Treatment of Cancer Core Quality-of-Life Questionnaire: the QLQ=C30 (+ 3). , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[17]  D. Osoba,et al.  Interpreting the significance of changes in health-related quality-of-life scores. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[18]  M. Sprangers,et al.  Response-shift bias: a challenge to the assessment of patients' quality of life in cancer clinical trials. , 1996, Cancer treatment reviews.